Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boston Children's Hospital
With
University of Arizona
Johns Hopkins University
Cystic Fibrosis Foundation
Age
12–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
CLINICIAN PARTICIPANTS:
1. A CF care team member from any discipline, designated by the site principal investigator (PI) and CF team
2. Willing to use MAP as part of CF care
PATIENT PARTICIPANTS:
1. Male or female patients ages ≥ 12 years of age at Study Visit 1
2. Documentation of a CF diagnosis (physician diagnosed)
3. Ability to understand verbal and written English
4. Access to mobile device such as a tablet or smartphone (iPhone/iPad/iTouch or Android device)
5. Willingness to use the MAP application
6. Currently taking at least one of the following chronic medications and willing to use AdhereTech pill bottles for oral medications and/or eTrack nebulizer for nebulized medications listed below: nebulized agents, dornase alfa, hypertonic saline, inhaled tobramycin, inhaled aztreonam, inhaled colistimethate, oral agents, azithromycin
CAREGIVER PARTICIPANTS (for Patient Participants age \< 18 years)
1. Child is consented to participate in the study.
2. Ability to understand verbal and written English
You may not be if
CLINICIAN PARTICIPANTS:
Previous use of MAP (with patient(s) or self) in the last 12 months - when used with patients, defined as use in 5 or more patients
PATIENT PARTICIPANTS:
1. Previous use of MAP in the last 12 months - defined as use for 4 weeks or longer in own care
2. Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data including, but not limited to, diagnosis of intellectual or developmental disability (e.g., autism); and/or history of lung transplant
3. Planned or scheduled hospitalization during study period of up to 36 weeks
CAREGIVER PARTICIPANTS:
(for Patient Participants age \< 18 years)
1\. Previous use of MAP in the last 12 months - defined as use for 4 weeks or longer in child's or own care
